- From: James Golden <jgolden@idc.com>
- Date: Mon, 4 Oct 2004 11:47:29 -0400
- To: public-swls-ws@w3.org
Abstract: Clearly, aspects of the semantic web such as ontologies, knowledge management, search, and uniform annotation of genomes offer unlimited opportunity for the life sciences. Many research projects exist in the public and industrial domain that have the potential to create products and services that can revolutionize biotechnology and medical science. However, we know from recent history that company creation around novel boinformatics solutions doesn't always result in commercial success or even broad adoption from a community that could clearly benefit from these tools. In this talk I will review some of the business creation issues in turning important knowledge management research into viable commercial opportunities. This talk will include an overview of what pharma and biotech companies spend on software and other IT, what sorts of problems pharma and biotech research face everyday and how pharma executives put a dollar value on tools that enable innovation and enhance productivity. Jim Golden, Ph.D. VP, Research Life Science Insights, an IDC Company 5 Speen Street Framingham, MA 01701 USA 508-935-4767 www.life-science-insights.com
Received on Monday, 4 October 2004 15:51:27 UTC